Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-17

Clinical Trial Update: Melatonin for Post Operative Delirium Prevention in Elderly Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating melatonin for prevention of postoperative delirium in elderly patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Menoufia University | Conditions: Delirium in Old Age | Phase 2 | Status: COMPLETED